Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Chan

Showing results (541-550 of 675) with videos related to

Pageof 68
Sort By:
Clinical Pharmacology and Therapeutics|October 16, 2021
CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 DiabetesKe Wang, Aimin Yang, Mai Shi, et al.
Diabetes Research and Clinical Practice|October 5, 2010
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes RegistryXilin Yang, Wing Yee So, Ronald C W Ma, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2004
The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathyWilson Y S Leung, Wing-Yee So, Peter C Y Tong, et al.
Diabetologia|September 1, 2006
End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes RegistryX L Yang, W Y So, A P S Kong, et al.
The Lancet Regional Health. Western Pacific|April 16, 2025
Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based studyHongjiang Wu, Haobin Zhou, Chuiguo Huang, et al.
Diabetes Research and Clinical Practice|January 1, 2015
Delivery of integrated diabetes care using logistics and information technology--the Joint Asia Diabetes Evaluation (JADE) programJuliana C N Chan, Risa Ozaki, Andrea Luk, et al.
Clinical Biochemistry|August 4, 2007
Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescentsAlice P S Kong, Gary W K Wong, Kai-Chow Choi, et al.
American Heart Journal|June 23, 2014
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trialRury R Holman, Mary A Bethel, Juliana C N Chan, et al.
Diabetes, Obesity & Metabolism|September 16, 2025
A 7-year prospective analysis of sustained benefits of multicomponent risk assessment and data-driven care in patients with type 2 diabetes: The Malaysian JADE ProgramJia-Xin Hoo, Ya-Feng Yang, Eric S H Lau, et al.
Archives of Internal Medicine|March 12, 2008
Development and validation of an all-cause mortality risk score in type 2 diabetes, Xilin Yang, Wing Yee So, et al.
Pageof 68

Showing results (541-550 of 675) with videos related to

Sort By:
Pageof 68
Clinical Pharmacology and Therapeutics|October 16, 2021
CYP2C19 Loss-of-function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 DiabetesKe Wang, Aimin Yang, Mai Shi, et al.
Diabetes Research and Clinical Practice|October 5, 2010
Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes RegistryXilin Yang, Wing Yee So, Ronald C W Ma, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2004
The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathyWilson Y S Leung, Wing-Yee So, Peter C Y Tong, et al.
Diabetologia|September 1, 2006
End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes RegistryX L Yang, W Y So, A P S Kong, et al.
The Lancet Regional Health. Western Pacific|April 16, 2025
Identifying and visualising temporal trajectories of hospitalisations for traditional and non-traditional complications in people with type 2 diabetes: a population-based studyHongjiang Wu, Haobin Zhou, Chuiguo Huang, et al.
Diabetes Research and Clinical Practice|January 1, 2015
Delivery of integrated diabetes care using logistics and information technology--the Joint Asia Diabetes Evaluation (JADE) programJuliana C N Chan, Risa Ozaki, Andrea Luk, et al.
Clinical Biochemistry|August 4, 2007
Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescentsAlice P S Kong, Gary W K Wong, Kai-Chow Choi, et al.
American Heart Journal|June 23, 2014
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trialRury R Holman, Mary A Bethel, Juliana C N Chan, et al.
Diabetes, Obesity & Metabolism|September 16, 2025
A 7-year prospective analysis of sustained benefits of multicomponent risk assessment and data-driven care in patients with type 2 diabetes: The Malaysian JADE ProgramJia-Xin Hoo, Ya-Feng Yang, Eric S H Lau, et al.
Archives of Internal Medicine|March 12, 2008
Development and validation of an all-cause mortality risk score in type 2 diabetes, Xilin Yang, Wing Yee So, et al.
Pageof 68